You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Nivolumab plus Ipilimumab in Advanced Melanoma
|
|---|---|
| Published in |
New England Journal of Medicine, June 2013
|
| DOI | 10.1056/nejmoa1302369 |
| Pubmed ID | |
| Authors |
Jedd D. Wolchok, Harriet Kluger, Margaret K. Callahan, Michael A. Postow, Naiyer A. Rizvi, Alexander M. Lesokhin, Neil H. Segal, Charlotte E. Ariyan, Ruth-Ann Gordon, Kathleen Reed, Matthew M. Burke, Anne Caldwell, Stephanie A. Kronenberg, Blessing U. Agunwamba, Xiaoling Zhang, Israel Lowy, Hector David Inzunza, William Feely, Christine E. Horak, Quan Hong, Alan J. Korman, Jon M. Wigginton, Ashok Gupta, Mario Sznol |
X Demographics
The data shown below were collected from the profiles of 138 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 39 | 28% |
| United Kingdom | 9 | 7% |
| Spain | 8 | 6% |
| Australia | 3 | 2% |
| Italy | 2 | 1% |
| Ireland | 2 | 1% |
| Canada | 2 | 1% |
| Argentina | 2 | 1% |
| Brazil | 2 | 1% |
| Other | 13 | 9% |
| Unknown | 56 | 41% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 94 | 68% |
| Practitioners (doctors, other healthcare professionals) | 22 | 16% |
| Scientists | 11 | 8% |
| Science communicators (journalists, bloggers, editors) | 11 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 2,307 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 19 | <1% |
| France | 7 | <1% |
| Germany | 6 | <1% |
| Canada | 4 | <1% |
| United Kingdom | 4 | <1% |
| Italy | 3 | <1% |
| Brazil | 3 | <1% |
| Belgium | 3 | <1% |
| Ecuador | 2 | <1% |
| Other | 18 | <1% |
| Unknown | 2238 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 455 | 20% |
| Student > Ph. D. Student | 441 | 19% |
| Student > Bachelor | 237 | 10% |
| Student > Master | 232 | 10% |
| Other | 174 | 8% |
| Other | 422 | 18% |
| Unknown | 346 | 15% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 712 | 31% |
| Agricultural and Biological Sciences | 433 | 19% |
| Biochemistry, Genetics and Molecular Biology | 292 | 13% |
| Immunology and Microbiology | 215 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 63 | 3% |
| Other | 180 | 8% |
| Unknown | 412 | 18% |
Attention Score in Context
This research output has an Altmetric Attention Score of 350. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 April 2024.
All research outputs
#94,302
of 26,017,215 outputs
Outputs from New England Journal of Medicine
#2,449
of 32,765 outputs
Outputs of similar age
#563
of 209,768 outputs
Outputs of similar age from New England Journal of Medicine
#16
of 329 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,765 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 122.4. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 209,768 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 329 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.